TWINSTRAND BIOSCIENCES, INC.

Profile

Company Names

TWINSTRAND BIOSCIENCES, INC.

Addresses

3131 ELLIOTT AVENUE, SUITE 750, SEATTLE, WA 98121

3131 ELLIOTT AVENUE, SUITE 750, SEATTLE, WA 98121

3131 ELLIOTT AVE, SUITE 750, SEATTLE, WA 98121

3131 ELLIOT AVENUE, SUITE 750, SEATTLE, WA 98121

3804 HUNTS POINT ROAD, BELLEVUE, WA 98004

Phone Numbers

206-202-8946
2062028946
(206) 284-2953
(617) 959-1959

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$84,977,112.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-06-20 
$10,278,497.00 
$25,735,608.00 
$15,457,111.00 
Equity 
5
2021-04-30 
$49,999,943.00 
$49,999,943.00 
$0.00 
Equity 
4
2019-12-16 
$16,301,834.00 
$16,301,834.00 
$0.00 
Equity 
3
2018-08-15 
$1,177,536.00 
$4,000,000.00 
$2,822,464.00 
Debt 
2
2017-08-30 
$5,280,338.00 
$5,531,171.00 
$250,833.00 
Equity 
1
2016-06-10 
$1,938,964.00 
$2,270,000.00 
$331,036.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RONNIE 
 
ANDREWS 
EXECUTIVE OFFICER
CALL LOOP INC   |  INSIGHT GENETICS, INC.   |  TWINSTRAND BIOSCIENCES, INC.   |  SIMBIOSYS, INC.
CHRISTOPHER 
 
BENOIT 
EXECUTIVE OFFICER, DIRECTOR
ENZYMATICS INC   |  TWINSTRAND BIOSCIENCES, INC.   |  TANGEN BIOSCIENCES, INC.   |  CANAL BIOSCIENCES, INC.
KELLIE 
 
BICKEL 
EXECUTIVE OFFICER
TWINSTRAND BIOSCIENCES, INC.
DAVID 
 
CANNER 
DIRECTOR
ANTIOS THERAPEUTICS INC.   |  TWINSTRAND BIOSCIENCES, INC.
ELENA 
 
CANT 
EXECUTIVE OFFICER
TWINSTRAND BIOSCIENCES, INC.
KAREN 
 
DABBS 
EXECUTIVE OFFICER
TWINSTRAND BIOSCIENCES, INC.
STEVE 
 
DOW 
DIRECTOR
PLECTIX BIOSYSTEMS INC   |  KABIRA TECHNOLOGIES INC   |  LIMERICK BIOPHARMA INC   |  ARTERYS INC   |  TWINSTRAND BIOSCIENCES, INC.   |  RUBICON MARKETS INC.   |  DIGITALOCEAN HOLDINGS, INC.
MICHELE 
 
FERNANDES 
EXECUTIVE OFFICER
TWINSTRAND BIOSCIENCES, INC.
CHRIS 
 
IGIELSKI 
EXECUTIVE OFFICER, DIRECTOR
NAVISONICS, INC.   |  STASYS MEDICAL CORP.   |  TWINSTRAND BIOSCIENCES, INC.
MICHAEL 
 
KRANDA 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PTC THERAPEUTICS, INC.   |  VACCINOGEN INC   |  BEAT BIOTHERAPEUTICS CORP   |  TWINSTRAND BIOSCIENCES, INC.
LAWRENCE 
 
LOEB 
DIRECTOR, PROMOTER
TWINSTRAND BIOSCIENCES, INC.
JASON 
 
MYERS 
DIRECTOR
JOBSITE123.COM, LLC   |  DSCS LLC   |  ARCHERDX, INC.   |  GENAPSYS, INC.   |  TWINSTRAND BIOSCIENCES, INC.   |  SWITCHBACK SYSTEMS, INC.
TERRY 
 
MYERSON 
DIRECTOR
TWINSTRAND BIOSCIENCES, INC.
MICHAEL 
 
PELLINI 
DIRECTOR
VINETI, INC.   |  OCTAVE BIOSCIENCE INC   |  TWINSTRAND BIOSCIENCES, INC.   |  NUSANO, INC.   |  EXAI BIO INC.
MIKE 
 
PELLINI 
DIRECTOR
ALPHA SOURCE, INC.   |  TWINSTRAND BIOSCIENCES, INC.   |  MEDCRYPT INC.
LINDEN 
 
RHOADS 
DIRECTOR
TWINSTRAND BIOSCIENCES, INC.   |  STASYS MEDICAL CORP.
JESSE 
 
SALK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TWINSTRAND BIOSCIENCES, INC.   |  CELLENS, INC.   |  CYTOTERRA INC.
MICHAEL 
 
SCHMITT 
DIRECTOR, PROMOTER
TWINSTRAND BIOSCIENCES, INC.   |  SPQI EQUITY MARKET NEUTRAL FUND L.P.   |  HH FUND 2 LLC
SOMA 
 
SOMASEGAR 
DIRECTOR
MADRONA ACCELERATION FUND, L.P.   |  ZIPSTORM, INC.   |  TWINSTRAND BIOSCIENCES, INC.   |  PLEXTRAC, INC.   |  MADRONA LABS HOLDINGS IV, LLC   |  MADRONA LABS HOLDINGS IV-A, LLC   |  APIOM, INC.   |  RELATIONALAI, INC.   |  OVATION.IO, INC.   |  OBSERVE, INC.
CHAD 
 
WAITE 
EXECUTIVE OFFICER, DIRECTOR
PLECTIX BIOSYSTEMS INC   |  ADAPX INC   |  XORI CORP   |  LIMERICK BIOPHARMA INC   |  VERDEZYNE INC   |  MIRINA CORP   |  ACYLIN THERAPEUTICS, INC.   |  ONCOFACTOR CORP   |  GROOVE BIOPHARMA CORP   |  AGGREGATE KNOWLEDGE INC   |  SYMFORM, INC.   |  CYRUS BIOTECHNOLOGY, INC.   |  TWINSTRAND BIOSCIENCES, INC.
CHAD 
 
WAITE, JR. 
EXECUTIVE OFFICER, DIRECTOR
TWINSTRAND BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-20 
2021-05-12
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-30 
2019-12-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-16 
2018-08-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-15 
2017-09-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-30 
2016-06-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-06-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#